Cinctive Capital Management LP Mirati Therapeutics, Inc. Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$39.16 - $88.71 $944,969 - $2.14 Million
-24,131 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$75.82 - $150.97 $30,327 - $60,388
-400 Reduced 1.63%
24,131 $1.98 Million
Q4 2021

Feb 14, 2022
BUY
$132.01 - $190.29 $1.77 Million - $2.56 Million
13,431 Added 121.0%
24,531 $3.6 Million
Q3 2021

Nov 15, 2021
BUY
$132.13 - $177.45 $1.47 Million - $1.97 Million
11,100 New
11,100 $1.96 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email